By Alex Philippidis

NEW YORK (GenomeWeb News) – Access to more of China's large patient populations and centralized health records, plus the ability to apply new technologies and expand on earlier joint projects, are among benefits foreseen by the Fred Hutchinson Cancer Research Center from the formal collaboration signed yesterday with the Chinese Center for Disease Control and Prevention.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.